Researcher Profile

Yoon, Suk Ran image
Yoon, Suk Ran(윤석란) 180

Immunotherapy Research Center (면역치료제연구센터)

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 180 (Search time: 0.002 seconds).

No. Year Title Type
180 2025

2025Patent

인체 말초 혈액의 자연살해세포 보다 더 높은 수준의 NCR, 살상능 및 IFN-γ 생산능력을 갖는 유사기억 자연살해세포의 제조 방법KR10-2021-7037367 (2021.11.16) / 10-2787753 (2025.03.24)최인표; 박수연; 윤석란김한나; 정솔지
Patent
179 2025

2025Report

항암 면역세포 치료기술 개발 = Development of anti-cancer immunotherapy연구책임자 : 윤석란 / 주관부처 : 과학기술정보통신부윤석란김태돈정해용노지윤이희구조희준조이숙김재화김세미
Report
178 2025

2025Report

NK세포 치료제 개발 = Development of NK cell therapy연구책임자 : 윤석란 / 주관부처 : 민간수탁윤석란김미정; 이윤희
Report
177 2025

2025Article

Enhanced antileukemic effect of NKp30b isoform of donor-derived NK cells infused after HLA-haploidentical allogeneic hematopoietic cell transplantation in high-risk AML and MDSBone Marrow Transplantation, vol. 60, pp. 546-548Eun Ji Choi; H H Lee; Suk Ran Yoon; In Pyo Choi; H Park; H S Park; Y Choi; J H Lee; J H Lee; H S Kim, et al.
Article
176 2025

2025Article

Resveratrol from peanut sprout extract promotes NK cell activation and antitumor activityBiomolecules & Therapeutics, vol. 33, no. 2, pp. 355-364Hyunmin Chung; Sung Ho Bak; Eunju Shin; Taeho Park; Jinwoo Kim; Hanseul Jeong; Haiyoung JungSuk Ran YoonJi Yoon Noh
Article
175 2025

2025Article

Therapeutic effects of TN13 peptide on acute respiratory distress syndrome and sepsis models in vivoJournal of Clinical Medicine, vol. 14, no. 6, pp. 1804-1804Jae-Eun Byun; Jae-Won Lee; Eun Ji Choi; Juhyun Lee; Seok Han Yun; Chan Ho Park; Hanna Kim; Mi Sun Kim; Suk Ran YoonTae-Don Kim, et al.
Article
174 2025

2025Article

Coptis japonica Makino ethanol extracts attenuates cancer cachexia induced muscle and fat wasting through inhibition of the STAT3 signaling pathwayFrontiers in Nutrition, vol. 12, pp. 1509086-1509086Yo Sep Hwang; Eun Sun Park; Jahyeong Han; Suk Ran YoonJun-Pil Jang; J S Lim; S H Park; J H Park; Hee Jun ChoHee Gu Lee
Article
173 2025

2025Research Project

면역미세환경 제어 기술 기반 난치암 치료 원천기술 개발 = Development of Therapeutic Technologies for Refractory Cancer Treatment Based on Immune Microenvironment Modulation연구책임자 : 조희준 / 사업기간 : 2025.01.01 ~ 2025.12.31
Research Project
172 2024

2024Article

PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasionCancer Cell International, vol. 24, pp. 73-73Jeewon Lim; Yo Sep Hwang; Hyang Ran Yoon; J Yoo; Suk Ran YoonHaiyoung JungHee Jun ChoHee Gu Lee
Article
171 2024

2024Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2024.01.01 ~ 2024.12.31
Research Project
170 2024

2024Article

Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysisLeukemia, vol. 38, no. 2, pp. 451-454K H Lee; S Lee; Y H Park; Y C Mun; E J Choi; Y Choi; H S Park; J H Lee; J H Lee; S Y Park, et al.
Article
169 2024

2024Research Project

NK세포 치료제 개발 = Development of NK cell therapy연구책임자 : 윤석란 / 사업기간 : 2024.07.01 ~ 2024.12.31
Research Project
168 2024

2024Article

Deficiency of thioredoxin-interacting protein (TXNIP) results in age-related thrombocytopenia due to megakaryocyte oxidative stressJournal of Thrombosis and Haemostasis, vol. 22, no. 3, pp. 834-850Eunju Shin; C Park; Taeho Park; Hyunmin Chung; H Hwang; Sung Ho Bak; Kyung-Sook ChungSuk Ran YoonTae-Don Kim; In Pyo Choi, et al.
Article
167 2024

2024Research Project

정신질환 관련 바이오마커의 생산 및 분석 기술 개발연구책임자 : 이희구 / 사업기간 : 2024.06.01 ~ 2025.05.31
Research Project
166 2024

2024Research Project

특정이자 활용사업(바이오의약연구부) = 특정이자 활용(바이오의약연구부)연구책임자 : 지승욱 / 사업기간 : 2024.03.18 ~ 2024.12.31
Research Project
165 2023

2023Patent

dcGMP를 유효성분으로 포함하는 면역 증강용 조성물KR10-2020-0163358 (2020.11.27) / 10-2563307 (2023.07.31)우의전; 이수진; 윤석란; 이윤희
Patent
164 2023

2023Article

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targetsFrontiers in Immunology, vol. 13, pp. 1089369-1089369Hee Young Kang; Soo Yun Lee; H M Kim; Su Ui Lee; H Lee; M Y Cho; Se-Chan Oh; Seok-Min Kim; H S Park; E H Han, et al.
Article
163 2023

2023Research Project

위탁시료(K046706)의 면역활성 평가시험 II = Evaluation of immune activity of K046706연구책임자 : 윤석란 / 사업기간 : 2023.01.09 ~ 2023.07.08
Research Project
162 2023

2023Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
161 2023

2023Article

NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapseNature Immunology, vol. 24, no. 3, pp. 463-473Se-Chan Oh; S E Kim; In Hwan Jang; Seok-Min Kim; Soo Yun Lee; Sunyoung Lee; In-Sun Chu; Suk Ran YoonHaiyoung Jung; In Pyo Choi, et al.
Article
1 2 3 4 5 6 7 8 9